How WeightWatchers Clinic Drives a 46% Quality of Life Boost at Work
New clinical insights reveal how holistic weight management support impacts employees’ daily functioning and work performance in measurable ways.
How WeightWatchers Clinic Drives a 46% Quality of Life Boost at Work
New clinical insights reveal how holistic weight management support impacts employees’ daily functioning and work performance in measurable ways.
When evaluating weight management programs in the workplace, conversations typically center on employee engagement, weight loss, and improved health metrics. While these measures are critical, some of the most telling results show up in the office, not on the scale.
The results from a recent clinical trial reveal a striking connection between comprehensive weight management support and work-related quality of life. Members taking a GLP-1 medication prescribed through WW Clinic reported a remarkable 46% improvement in their work-related quality of life.1 The result reflects more than just better health outcomes – it connects weight management with key workplace metrics, such as productivity.
Solutions Rooted in Science
How do our programs help members – and employers – realize these kinds of results? Our ongoing commitment to science, research, and innovation.
Our WeightWatchers platform has long been recognized as one of the most scientifically studied and research-proven weight management solutions available. With over 180 published studies, including 40+ randomized controlled trials, validating our approach, research like this latest clinical trial has always guided the evolution of our various programs.
As the science around weight loss and weight management advances, our program continues to adapt, providing science-led behavioral and access to clinical support that addresses modern needs.
What the Latest Research Shows
The recent six-month, single-arm clinical trial followed 180 members taking the GLP-1 medications semaglutide or tirzepatide. Most participants in the trial were female, with an average age of 44 and an average body mass index (BMI) of 37.1 kg/m1.
The objective of the trial was to evaluate the effectiveness of WeightWatchers’ GLP-1 Companion Program, which includes medication management through the WW Clinic and access to our GLP-1 nutrition program, GLP-1-tailored workshops, and registered dietitian and fitness consults.
The health outcomes of the six-month trial were significant.1
- 12.3% average body weight loss, with two-thirds of participants losing more than 10% of their body weight.
- 34.7% improvement in diet quality, with increased self-reported consumption of vegetables and decreases in fried foods, sweets, and sugar-sweetened beverages.
- 1 hour per week decrease in sedentary time, with strength training days increasing by 53.2%.
The Game Changer for Employers: Quality of Life at Work
The clinical trial examined weight-related quality of life, with participants reporting a 53% improvement, fueled by positive changes in quality of life related to physical function, self-esteem, sexual life, and public distress.1
However, it’s the 46% boost in work-related quality of life that is particularly compelling for employers. This type of increase has the potential to produce significant ripple effects, including increased productivity, higher job satisfaction, improved employee engagement, and potential reductions in absenteeism and presenteeism.
The WeightWatchers full-spectrum platform, with its seamless integration of medication management and behavioral support, is about more than weight loss. These beyond-the-scale outcomes demonstrate a direct connection between employee support and an organization’s ability to foster a healthier, happier, and more productive workforce.
A Full-Spectrum Platform That Works
Most people associate WeightWatchers with behavioral weight management. But our expertise extends beyond weight loss. While behavior modification is the cornerstone of our platform, it’s just one element of the weight management solutions we provide to our 300+ commercial clients and millions of members worldwide.
Backed by the evolving science, we’ve partnered with employers and health plans for over 35 years, delivering an evidence-based, scalable platform that flexes to meet the full spectrum of weight health needs – and budgets.
Today’s WeightWatchers isn’t one-size-fits-all. No matter what your weight management objectives are – or whether you cover GLP-1 medications or not – our platform provides individualized experiences that help to achieve weight health at scale through a personalized mix of behavioral, clinical, and community care.
We combine it with deep enrollment and engagement expertise that provides purpose-built experiences that meet members where they are, engaging them through personalized communications, just-in-time notifications, and gamification. As the research demonstrates, members improve their quality of life physically, personally, and professionally. The proof is in our 90%+ satisfaction rate among commercial clients.2
Behind it all, we continue to focus on clinical research that validates the efficacy of our programs and leads the way to better weight health, metabolic health, and overall well-being. The results are meaningful – and sustainable.
- 43% increase in healthy habits with our Behavioral Program.3
- 54% greater weight loss for members taking an anti-obesity medication when combined with our Behavioral Program.4
Investing in a Healthier Future
As a trusted partner in population weight health, we’re ready to help you bring it all together: effective weight loss, improved health habits, and enhanced quality of life, overall and at work.
Reach out to learn more about how the platform can flex to fit your strategy and seamlessly integrate into your benefits offering to deliver lasting results for your members and your organization.
1Based on a 6-month clinical trial (n=180) of individuals who were enrolled between February–April 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program. Heinberg et al. Psychosocial Outcomes in a Telemedicine and Long-Acting Incretin Specific Behavioral Intervention. Manuscript under review. Funded by WW International, Inc.
2 Based on WeightWatchers for Business internal client satisfaction survey results; Large and Jumbo Clients; Sept. 2022.
3 Based on a 6-month randomized controlled trial (n=376) that compared participants following WW to those given standard nutritional guidelines alone. Palacios et al. 2025. Manuscript in draft. Funded by WW International, Inc.
4 Based on a 12-week randomized controlled trial (n=101) that compared taking bupropion & naltrexone medications on their own to taking bupropion & naltrexone with the WeightWatchers behavioral program, including the PointsⓇ Program. Jones et al. Manuscript under review. Funded by WW International, Inc.
